Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Year range
1.
RBCF, Rev. bras. ciênc. farm. (Impr.) ; 44(2): 181-184, abr.-jun. 2008. ilus
Article in Portuguese | LILACS | ID: lil-488714

ABSTRACT

O aumento do uso de radiofármacos PET (Pósitron Emission Tomography) vem chamando a atenção dos profissionais da área de Medicina Nuclear e Farmácia, assim como das agências reguladoras. O objetivo é prover parâmetros estruturais e legais mínimos como uma referência nacional em radiofarmácia, que possam auxiliar as agências regulatórias, focando principalmente no projeto fabril.


The increasing use of radiopharmaceuticals for PET (Positron Emission Tomography) has come to the attention of nuclear medicine staff and regulatory bodies. The aim of this study is to provide a national reference in radiopharmacy that could help all nuclear medicine staff and specially the Brazilian's regulatory bodies focused on the industrial project.


Subject(s)
Radiopharmaceuticals/standards , Legislation, Drug , Brazil , Good Manufacturing Practices
SELECTION OF CITATIONS
SEARCH DETAIL